J&J capitalizes on Nanobiotix cash crunch to capture late-phase cancer candidate for $30M upfront

0

10.07.2023 12:23

Fiercebiotech.com

J&J capitalizes on Nanobiotix cash crunch to capture late-phase cancer candidate for $30M upfront ntaylor Mon, 07/10/2023 - 05:23

СМИ24.net — правдивые новости, непрерывно 24/7 на русском языке с ежеминутным обновлением *